Insider Transactions in Q2 2024 at Conmed Corp (CNMD)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Stanley W Peters Iii President AS and AET |
SELL
Open market or private sale
|
Direct |
4,000
-98.45%
|
$284,000
$71.82 P/Share
|
|
Jun 14
2024
|
Stanley W Peters Iii President AS and AET |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+49.61%
|
$164,000
$41.93 P/Share
|
|
May 31
2024
|
Brian Concannon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
302
+3.04%
|
-
|
|
May 31
2024
|
Jerome J. Lande Director |
BUY
Exercise of conversion of derivative security
|
Direct |
302
+7.26%
|
-
|
|
May 31
2024
|
Charles Farkas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
302
+1.5%
|
-
|
|
May 31
2024
|
David M Bronson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
302
+1.77%
|
-
|
|
May 31
2024
|
John L Workman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
302
+1.46%
|
-
|
|
May 31
2024
|
Barbara J Schwarzentraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
302
+7.25%
|
-
|
|
May 31
2024
|
La Verne H Council Director |
BUY
Exercise of conversion of derivative security
|
Direct |
302
+7.8%
|
-
|
|
May 31
2024
|
Martha Goldberg Aronson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
302
+2.47%
|
-
|
|
May 13
2024
|
David M Bronson Director |
BUY
Open market or private purchase
|
Direct |
1,350
+7.58%
|
$97,200
$72.09 P/Share
|
|
May 08
2024
|
Barbara J Schwarzentraub Director |
BUY
Open market or private purchase
|
Indirect |
1,442
+50.0%
|
$99,498
$69.26 P/Share
|
|
May 06
2024
|
Martha Goldberg Aronson Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+50.0%
|
$140,000
$70.98 P/Share
|
|
Apr 30
2024
|
Pat Beyer Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+21.73%
|
$204,000
$68.3 P/Share
|